Recent study suggested that cytotoxic CD8+ T cells in vitiligo perilesions may dictate the fate of transplantation [17], and strategies against CD8+ T cell activation might be beneficial for patients undergoing melanocyte transplantation. Here, CD8A is linked to vitiligo.